Seeking Alpha

Red Robin released its Q2 results last month posting disappointing results that are down from 2019. Read more about RRGB Q2 results…

Uranium Royalty has the right idea on how to play the complicated uranium market. Click here to see why we remain neutral on…

The gold market was choppy and made a low of $1780.60. Our AI algorithm expects buyers to come into the market at these levels….

Board experience at Jarden is promising. Attractive valuation that does not require expansion or rerating.

Seagen has an extensive pipeline of potential therapies – the basis for future value growth. See why an FDA decision could be…

Chewy’s current valuation is not supported by the underlying fundamentals. It’s best to wait for more opportunistic price levels…

InMode is operating like Align Technology’s (ALGN) early days. See why I feel that the market is not considering INMD’s prospects…

Matinas stock went up nearly 30% after publishing phase 2 meningitis data. Check out why I think MTNB stock will look more attractive…

While I expect that the stock has more room to fall (hence the neutral rating), investors looking for dividend growth in the…